MAT-304

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMAT-304
Drug Alias Nameanti-CD5 antibody (MAT Biopharma)anti-CD5 antibody (MABLife)MAT-304
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionT-cell surface glycoprotein CD5 inhibitors
TargetsT-cell surface glycoprotein CD5
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMablife
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMablife
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A